Blood Marker Could Help ID Peripheral Artery Disease Risk
A study finds high levels of a specific protein circulating in the blood can accurately detect severe peripheral artery disease risk.
Category: Cardiovascular
Cardiovascular
Latest
Cardiovascular
Latest
Zora Biosciences Licenses Ceramide Technology to Quest Diagnostics
Quest plans to develop a test service based on Zora's ceramide technology as an aid in identifying patients at risk for cardiovascular-related disease and death.
Cardiovascular
LatestRandox Launches Adiponectin Assay for Metabolic Risk Assessment
The Randox adiponectin assay is a liquid, ready-to-use reagent that can be used on a wide range of clinical chemistry analyzers.
January 2019 Product Spotlight: 2019 Emerging Technologies Showcase
Nano-Signature Discovery Could Revolutionize Cancer Diagnosis A quick and easy test to...
Read More
University of Manchester and Owlstone Medical Awarded £250,000 to Advance Asthma Diagnostics
The study will collect breath samples from asthmatic patients and healthy controls to analyze breath-based biomarkers.
Read MoreCanopy Biosciences Licenses Technology for Error-Corrected Sequencing
The license encompasses both a novel method and bioinformatic tools that combine to improve the level of detection in NGS, allowing for the identification of ultrarare gene variants.
Read MoreNumares and Mayo Clinic Laboratories Collaborate on Nuclear Magnetic Resonance Diagnostics
The new pathways will focus on conditions such as cardiovascular disease, kidney disease, and liver cancer.
Read More
Cardis Partners Develop Photonic-Based Device to Screen for Arterial Stiffness and Cardiovascular Diseases
The prototype is a mobile, low-cost, point-of-care screening device that takes measurements in a fast, reproducible, and reliable way, with minimal patient contact and minimal skills from the operator.
Read More
FDA Clears MenoCheck as an Aid in the Determination of Menopausal Status
The MenoCheck assay was developed to aid physicians in determining the status of women during menopausal transition.
Read More
Collaboration Brings Cardiac Test to Canada
The simple blood test identifies individuals who are at risk of experiencing a heart attack, and for whom early intervention can help.
Read More
Mayo Clinic Launches Blood Test to Assess Heart Attack Risk
The test measures blood concentrations of plasma ceramides, a class of lipids that are highly linked to cardiovascular disease processes.
Read More
Panel Identifies Inherited Early Atherosclerosis Diagnosis and Risk
The 84-gene panel is designed to identify patients with a genetic signature for inherited premature coronary or atherosclerotic disease, such as familial hypercholesterolemia, as well as mature onset diabetes of the young.
Read MoreNovel Anticoagulant Candidates Developed for Cardiovascular Market
Candidates have demonstrated comparable preclinical efficacy to existing anticoagulants but with substantially lower bleeding liability.
Read More
Cardiovascular Disease Diagnostics and Testing
Current and emerging cardiac markers are signaling improved testing for better patient outcomes.
Read MoreGD Biosciences Expands Cardiac Test Availability
Global demand for the company’s heart disease blood test prompts international expansion.
Read More
Study Signifies Progress for Cardiovascular Disease Treatment and Personalized Medicine
The DiscoveryMap platform from Myriad RBM has identified combinations of 15 protein biomarkers associated with cardiovascular events in patients with diabetes.
Read MoreTroponin I Assay, Analyzer Designed for Quick Diagnoses at Point of Care
The assay delivers cardiac troponin I results in about 15 minutes from either whole blood or plasma samples.
Read MoreGenetic Testing Panel Investigates Inherited Cardiovascular Diseases
The next-generation sequencing based molecular test detects genomic variations in 213 genes related to familial cardiovascular diseases.
Read More